Sterling Capital Management’s Pacira BioSciences PCRX Stock Holding History

Sterling Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$457K	Buy
2025 Q2	$382K	Buy
2025 Q1	$387K	Buy
2024 Q4	$25.7K	Buy
2024 Q3	$2.33K	Buy
2015 Q4	–	Sell
2015 Q3	$310K	Buy
2015 Q1	–	Sell
2014 Q4	$261K	Buy
2014 Q3	$278K	Buy